CytomX Therapeutics announces senior management hires

|About: CytomX Therapeutics (CTMX)|By:, SA News Editor

CytomX Therapeutics (CTMX +3.1%) appoints Nick Galli, J.D., as Senior VP, Chief Business Officer and Leslie Robbins, J.D., as Senior VP, Intellectual Property.

Mr. Galli, most recently held the position of vice president, business development at Denali Therapeutics.

Ms. Robbins joins CytomX from Coherus BioSciences where she held the role of vice president, intellectual property.

Subscribe for full text news in your inbox